/Investor DB

Canaan Partners — 2022 Investments

11 investments dated 2022 · listed companies and verified rows first · show all

Aceissaceiss.comSeed · Aug 2022 · $3M

Aceiss detects unauthorized employee access to company systems and monitors user privileges across applications to prevent cyber attacks.

CybersecurityDeveloper ToolsEnterprise Software

Co-investorsConnecticut InnovationsInsight Partners

Altimate Incaltimate.aiin𝕏Sep 2022

Altimate provides an open-source, tech-stack-agnostic agentic data platform whose AI data agents automate tasks such as building data pipelines, migrating workloads, managing infrastructure, and enforcing data governance.

AI & Machine LearningData & InfrastructureDeveloper ToolsSunnyvale, US

Anand Gupta(Executive Officer, Director)inPradnesh Patil(Executive Officer, Director)inAtul Pawar(Director)

Co-investorsSierra Ventures

Earnipayearnipay.comSeed · Feb 2022 · $4M

Lekki, NG

Nonso O(Founder)Busayo Oyetunji(Founder)Busayo-Onome Oyetunji(Founder)Joshua Ajayi(Founder)Nonso Onwuzulike(Founder)

Co-investorsVentures PlatformXYZ Venture CapitalMusha Ventures

Instrumentalinstrumental.financeFeb 2022

Strategy hub enabling DeFi yield access across multiple chains and layers for comprehensive cross-chain growth.

Co-investorsAdvanced BlockchainBAM ElevateEclipse VenturesRoot Ventures Manager, Llc

Mantramantrachain.ioJan 2022 · $22M

MANTRA is a modular, compliance-oriented Layer 1 blockchain built for DeFi and real-world asset (RWA) tokenization.

Co-investorsLvna CapitalShorooq PartnersWWVentures14WAlumni VenturesBaleon Capital+8 more

Mantramantra.msinJan 2022 · $22M

Mantra provides cybersecurity awareness and phishing training designed to turn employees into an active line of defense against attacks that exploit human error.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaS

Gaspard Droz(Founder)in

Co-investorsAxeleo CapitalOneRagtime14WAlumni VenturesBaleon CapitalCity Light+2 more

Rondo Therapeuticsrondotx.cominSeries A · Mar 2022 · $67M

Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.

BiotechHealthtech

Shelley Force Aldred(Co-Founder & Chief Executive Officer)inNathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)

Co-investorsDementia Discovery FundRed Tree VentureSV Health InvestorsJohnson & Johnson Innovation – JJDCNovo Holdings

withcowith.coSeries A · Feb 2022 · $28M

WITH.CO helps small businesses such as corner stores, theaters, and restaurants acquire the buildings they operate from by letting their customers, neighbors, and regulars invest and share ownership.

FintechImpact & Social GoodPropTech

Kevin Song(Founder)Taylor Savage(Founder)

Co-investorsInitialized CapitalNFXSecond Century VenturesBoxGroupFounders FundSciFi VC

Workmotionworkmotion.comin𝕏Series B · Jun 2022 · $40M

WorkMotion is an Employer of Record (EOR) platform for hiring, onboarding, paying, and managing international employees and contractors across 160+ countries without opening local entities.

Future of WorkHR TechSaaSBerlin, DE

Felix Steffens(Founder)inKarim Zaghloul(Founder)inCarsten Lebtig(Founder)inHR Tech SaaS Felix Steffens(Founder)Islam Abdelaziz(VP Engineering / CTO)Jan-Peter Böckstiegel(Founder)

Co-investorsActivant CapitalBootstrap EuropeGR CapitalPICUS CAPITALSeed+SpeedXAnge+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Mosey WorksMosey

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.